Drug recall · March 6, 2013
Dextroamphetamine Sulfate Extended Release Capsules recall
Why: Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for CorePharma, LLC Middlesex, NJ 08846 NDC 64720-327-09
- Lots / codes
Lot 238316, exp 01/31/2014
- Quantity
- 1,176 bottles
- Company
- Amedra Pharmaceuticals LLC, Horsham, PA
- Distribution
- Nationwide and Puerto Rico.
- Initiated
- December 4, 2012 · Voluntary: Firm initiated
- Classified
- February 27, 2013
- Reported
- March 6, 2013
- Ended
- March 21, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dextroamphetamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.